Jaguar Health annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Jaguar Health's operating margin was −398.82% for fiscal 2025.
View full Jaguar Health company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −398.82% | −135.06 pp |
| 2024 | 2024-12-31 | −263.76% | +87.55 pp |
| 2023 | 2023-12-31 | −351.31% | −63.46 pp |
| 2022 | 2022-12-31 | −287.85% | +651.21 pp |
| 2021 | 2021-12-31 | −939.05% | −655.12 pp |
| 2020 | 2020-12-31 | −283.93% | +217.33 pp |
| 2019 | 2019-12-31 | −501.26% | +196.72 pp |
| 2018 | 2018-12-31 | −697.98% | +87.29 pp |
| 2017 | 2017-12-31 | −785.27% | +8814.57 pp |
| 2016 | 2016-12-31 | −9,599.84% | −4783.17 pp |
| 2015 | 2015-12-31 | −4,816.67% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −620.16% | −351.38 pp |
| Q1 2026 | 2026-03-31 | 50.23% | +475.75 pp |
| Q4 2025 | 2025-12-31 | −656.63% | −424.17 pp |
| Q3 2025 | 2025-09-30 | −234.77% | −1.12 pp |
| Q2 2025 | 2025-06-30 | −268.78% | −4.28 pp |
| Q1 2025 | 2025-03-31 | −425.52% | −76.09 pp |
| Q4 2024 | 2024-12-31 | −232.46% | +79.91 pp |
| Q3 2024 | 2024-09-30 | −233.66% | −33.07 pp |
| Q2 2024 | 2024-06-30 | −264.50% | −70.66 pp |
| Q1 2024 | 2024-03-31 | −349.43% | −82.58 pp |
| Q3 2023 | 2023-09-30 | −312.37% | +568.41 pp |
| Q4 2020 | 2020-12-31 | −200.58% | +186.14 pp |
| Q3 2020 | 2020-09-30 | −193.83% | +497.53 pp |
| Q2 2020 | 2020-06-30 | −266.85% | +355.78 pp |
| Q1 2020 | 2020-03-31 | −880.78% | −517.57 pp |
| Q4 2019 | 2019-12-31 | −386.72% | +372.14 pp |
| Q3 2019 | 2019-09-30 | −691.37% | −116.65 pp |
| Q2 2019 | 2019-06-30 | −622.63% | +178.31 pp |
| Q1 2019 | 2019-03-31 | −363.21% | +274.35 pp |
| Q4 2018 | 2018-12-31 | −758.86% | +582.29 pp |
| Q3 2018 | 2018-09-30 | −574.72% | +92.43 pp |
| Q2 2018 | 2018-06-30 | −800.94% | −538.79 pp |
| Q1 2018 | 2018-03-31 | −637.56% | −166.31 pp |
| Q4 2017 | 2017-12-31 | −1,341.15% | +10135.27 pp |
| Q3 2017 | 2017-09-30 | −667.15% | +5645.42 pp |
| Q2 2017 | 2017-06-30 | −262.15% | +13855.21 pp |
| Q1 2017 | 2017-03-31 | −471.25% | +9188.38 pp |
| Q4 2016 | 2016-12-31 | −11,476.42% | −6458.39 pp |
| Q3 2016 | 2016-09-30 | −6,312.57% | −2018.50 pp |
| Q2 2016 | 2016-06-30 | −14,117.36% | — |
| Q1 2016 | 2016-03-31 | −9,659.63% | — |
| Q2 2015 | 2015-06-30 | −5,018.03% | — |
| Q1 2015 | 2015-03-31 | −4,294.07% | — |
Over the last five reported fiscal years, Jaguar Health's operating margin decreased from −283.93% to −398.82%, a change of −114.89 percentage points. The latest reported quarter, Q2 2026, shows −620.16%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jaguar Health filings at SEC.gov ↗